28 September 2024
Clifford Chance advises CBC Group and Mubadala on the acquisition of UCB’s mature business (neurology and allergy) in China
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Yang Yi Lead | Clifford Chance | Partner | Not stated | Shanghai |
| Maggie Lo | Clifford Chance | Partner | Not stated | Not stated |
| Bao Fang | Clifford Chance | Counsel | Not stated | Not stated |
| Carolin Kemmner | Clifford Chance | Counsel | Not stated | Not stated |
| Dayu Man | Clifford Chance | Counsel | Not stated | Not stated |
| Cynthia Mo | Clifford Chance | Senior associate | Not stated | Not stated |
| Haaike Wouters | Clifford Chance | Associate | Not stated | Not stated |
| Annabel Joschko | Clifford Chance | Associate | Not stated | Not stated |
| Jia Yin Leong | Clifford Chance | Associate | Not stated | Not stated |
| Ashley Tan | Clifford Chance | Trainee | Not stated | Not stated |
Stated terms
- Stated value
- USD 680m (US$680 million)
- What the figure measures
- Total transaction value
- Client
- Not stated
- Counterparties
- UCB (Sell-side)